Compared with non-obese controls, patients with NAFLD without obesity had higher fasting glucose levels and a lower adiponectin-to-leptin ratio (Supplementary Table 1 and Fig. 7c–e). This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.